Viewing Study NCT06837792

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-02-04 @ 1:02 AM
Study NCT ID: NCT06837792
Status: RECRUITING
Last Update Posted: 2025-04-29
First Post: 2024-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
Sponsor: Yonsei University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None low HER2, advanced breast cancer, T-DXd View